Aurora Cannabis (TSE:ACB) Stock Price Up 0.2% - Here's What Happened

Key Points

• Aurora Cannabis shares rose 0.2% to C$5.34 in Wednesday trading, while volume fell 55% below the average daily level.
• Analysts have a mixed but generally positive view: the stock holds a consensus “Moderate Buy” rating with a C$6.20 target, though several firms recently reduced their price targets.
• The company reported a quarterly loss of C$0.07 per share on C$67.55 million in revenue, alongside a negative net margin of 9.53% and negative return on equity of 5.21%.

Aurora Cannabis Inc. (TSE:ACB - Get Free Report) rose 0.2% during trading on Wednesday . The company traded as high as C$5.37 and last traded at C$5.34. Approximately 187,258 shares changed hands during mid-day trading, a decline of 55% from the average daily volume of 419,252 shares. The stock had previously closed at C$5.33.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ACB shares. BMO Capital Markets raised shares of Aurora Cannabis to a "hold" rating in a research report on Wednesday, August 5th. TD dropped their price objective on Aurora Cannabis from C$10.00 to C$8.00 and set a "buy" rating on the stock in a report on Friday, June 12th. Canaccord Genuity Group dropped their price target on Aurora Cannabis from C$6.50 to C$5.00 and set a "buy" rating on the stock in a research note on Tuesday, June 30th. Finally, ATB Cormark Capital Markets lowered Aurora Cannabis from an "outperform" rating to a "tender" rating and cut their price target for the stock from C$6.50 to C$5.60 in a research report on Wednesday, August 19th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of C$6.20.

Aurora Cannabis Stock Up 0.2%

The company has a current ratio of 5.36, a quick ratio of 2.48 and a debt-to-equity ratio of 4.30. The company has a market capitalization of C$330.85 million, a price-to-earnings ratio of -2.75 and a beta of 0.42. The firm's 50 day simple moving average is C$4.53 and its 200-day simple moving average is C$4.63.

Aurora Cannabis (TSE:ACB - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. The firm had revenue of C$67.55 million during the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%. On average, sell-side analysts anticipate that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.